BRIEF-Aralez Pharmaceuticals says resubmitted to NDA for Yosprala

Tue Mar 15, 2016 6:37am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

March 15 (Reuters) - Aralez Pharmaceuticals Inc :

* Has resubmitted to U.S. FDA NDA for its investigational candidate Yosprala Source text for Eikon: Further company coverage: (Bengaluru Newsroom +91 80 6749-1130; within U.S. +1 646 223 8780)